Richard F. Wallman
Richard F. Wallman's purchase track record
How the stock did after each of Richard F. Wallman's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 6/1/2026 | CECO | $1.54M | -9.8% | pending | — |
| 4/29/2026 | CECO | $1.10M | -17.5% | pending | — |
| 8/29/2025 | CECO | $340K | +14.4% | +32.6% | +6.5% |
| 2/26/2025 | CECO | $378K | +15.1% | +90.9% | +8.8% |
| 8/30/2024 | CECO | $288K | +10.7% | -14.1% | +5.4% |
| 5/21/2024 | CECO | $98K | +7.9% | +17.8% | +11.2% |
| 5/1/2024 | CECO | $110K | +32.7% | +11.8% | +15.8% |
| 3/6/2024 | CECO | $989K | +21.1% | +30.0% | +8.1% |
| 9/18/2023 | CECO | $160K | +26.9% | +32.4% | +15.6% |
| 9/7/2023 | CECO | $165K | +41.2% | +48.4% | +15.9% |
| 8/24/2023 | CRL | $199K | -0.9% | +24.3% | +16.2% |
| 3/7/2023 | CECO | $151K | -15.1% | -7.7% | +12.8% |
| 2/23/2023 | CRL | $386K | -14.2% | -12.6% | +9.1% |
| 2/14/2023 | ROP | $425K | +7.9% | +16.3% | +7.3% |
| 12/2/2022 | CRL | $328K | +4.2% | -9.9% | +5.2% |
| 11/4/2022 | ROP | $390K | +8.8% | +16.0% | +9.7% |
| 8/9/2022 | CECO | $179K | +31.6% | +63.5% | +1.0% |
| 3/21/2022 | CECO | $174K | -0.2% | +64.2% | -12.6% |
| 12/20/2021 | CECO | $89K | -1.4% | -1.5% | -17.6% |
| 12/9/2021 | CECO | $183K | -8.9% | +11.2% | -13.9% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
CECO Environmental Named Among Stocks Facing Headwinds. A recent market analysis identified CECO Environmental as one of three growth stocks currently facing headwinds, contrasting it with peers expected to flourish. This classification highlights potential challenges in the company's near-term outlook. The stock is trading near its 52-week low, with a high P/E ratio indicating that current earnings are low relative to the share price.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
CRL Analyst Targets Rise After UBS Reinstates Coverage. Charles River Laboratories saw its average analyst price target increase to $305.00, driven by UBS reinstating coverage with a $357.00 target. This move follows reports of stabilizing demand and increased interest in animal model markets. The stock is currently trading below its 52-week high, with technical indicators showing support near $181.76.
Transaction History
| ROP | ▼ Sell | Open Market | 6,434 | $2.3M | 7/24/2026 | View on chart |
| CECO | ▲ Buy | Grant | 3,443 | $0 | 6/1/2026 | View on chart |
| CECO | ▲ Buy | Open Market | 20,000 | $1.5M | 6/1/2026 | View on chart |
| ROP | ▲ Buy | Grant | 1,191 | $0 | 5/20/2026 | View on chart |
| CECO | ▲ Buy | Open Market | 10,000 | $733K | 4/29/2026 | View on chart |
| CECO | ▲ Buy | Open Market | 5,000 | $369K | 4/29/2026 | View on chart |
| ROP | ▲ Buy | Grant | 92 | $0 | 3/16/2026 | View on chart |
| ROP | ▼ Sell | Gift | 4,000 | $0 | 12/8/2025 | View on chart |
| ROP | ▲ Buy | Grant | 64 | $0 | 9/15/2025 | View on chart |
| CECO | ▲ Buy | Open Market | 3,000 | $141K | 9/5/2025 | View on chart |
| CECO | ▲ Buy | Open Market | 3,000 | $133K | 8/29/2025 | View on chart |
| CECO | ▲ Buy | Open Market | 1,500 | $66K | 8/29/2025 | View on chart |
| ROP | ▼ Sell | Open Market | 352 | $196K | 7/22/2025 | View on chart |
| ROP | ▼ Sell | Gift | 4,000 | $0 | 7/22/2025 | View on chart |
| ROP | ▲ Buy | Grant | 675 | $0 | 6/11/2025 | View on chart |
| CECO | ▲ Buy | Grant | 9,792 | $0 | 6/3/2025 | View on chart |
| CECO | ▲ Buy | Open Market | 1,000 | $25K | 2/26/2025 | View on chart |
| CECO | ▲ Buy | Open Market | 14,000 | $353K | 2/26/2025 | View on chart |
| ROP | ▼ Sell | Gift | 6,000 | $0 | 1/31/2025 | View on chart |
| ROP | ▼ Sell | Open Market | 351 | $202K | 1/31/2025 | View on chart |
| ROP | ▼ Sell | Gift | 4,000 | $0 | 12/11/2024 | View on chart |
| CRL | ▼ Sell | Open Market | 3,371 | $727K | 11/7/2024 | View on chart |
| CRL | ▼ Sell | Open Market | 3,250 | $704K | 11/7/2024 | View on chart |
| CRL | ▼ Sell | Open Market | 1,000 | $217K | 11/7/2024 | View on chart |
| CRL | ▼ Sell | Gift | 4,540 | $0 | 11/6/2024 | View on chart |
| ROP | ▼ Sell | Gift | 2,000 | $0 | 10/28/2024 | View on chart |
| ROP | ▼ Sell | Open Market | 417 | $228K | 10/25/2024 | View on chart |
| ROP | ▼ Sell | Open Market | 1,000 | $550K | 10/24/2024 | View on chart |
| ROP | ▼ Sell | Open Market | 1,000 | $550K | 10/24/2024 | View on chart |
| ROP | ▼ Sell | Gift | 11,500 | $0 | 9/18/2024 | View on chart |
| ROP | ▼ Sell | Gift | 2,500 | $0 | 9/18/2024 | View on chart |
| CECO | ▲ Buy | Open Market | 10,000 | $288K | 8/30/2024 | View on chart |
| CECO | ▲ Buy | Grant | 798 | $0 | 6/30/2024 | View on chart |
| ROP | ▲ Buy | Grant | 703 | $0 | 6/13/2024 | View on chart |
| CECO | ▲ Buy | Open Market | 4,000 | $98K | 5/21/2024 | View on chart |
| CECO | ▲ Buy | Grant | 9,466 | $0 | 5/20/2024 | View on chart |
| CRL | ▲ Buy | Grant | 559 | $128K | 5/13/2024 | View on chart |
| CRL | ▲ Buy | Grant | 460 | $105K | 5/13/2024 | View on chart |
| CECO | ▲ Buy | Open Market | 5,000 | $110K | 5/1/2024 | View on chart |
| CECO | ▲ Buy | Grant | 1,000 | $0 | 3/31/2024 | View on chart |
| CECO | ▲ Buy | Open Market | 50,000 | $989K | 3/6/2024 | View on chart |
| CECO | ▲ Buy | Grant | 1,186 | $0 | 1/5/2024 | View on chart |
| CECO | ▲ Buy | Grant | 1,462 | $0 | 10/6/2023 | View on chart |
| CECO | ▲ Buy | Open Market | 10,000 | $160K | 9/18/2023 | View on chart |
| CECO | ▲ Buy | Open Market | 12,000 | $165K | 9/7/2023 | View on chart |
| CRL | ▲ Buy | Open Market | 1,000 | $199K | 8/24/2023 | View on chart |
| CECO | ▲ Buy | Grant | 1,054 | $0 | 7/10/2023 | View on chart |
| ROP | ▲ Buy | Grant | 843 | $0 | 6/14/2023 | View on chart |
| CECO | ▲ Buy | Grant | 8,299 | $0 | 6/5/2023 | View on chart |
| CRL | ▲ Buy | Grant | 664 | $0 | 5/15/2023 | View on chart |
| CECO | ▲ Buy | Grant | 1,030 | $0 | 4/12/2023 | View on chart |
| CECO | ▲ Buy | Open Market | 10,000 | $151K | 3/7/2023 | View on chart |
| CRL | ▲ Buy | Open Market | 1,750 | $386K | 2/23/2023 | View on chart |
| ROP | ▲ Buy | Open Market | 1,000 | $425K | 2/14/2023 | View on chart |
| CRL | ▲ Buy | Open Market | 1,500 | $328K | 12/2/2022 | View on chart |
| ROP | ▲ Buy | Open Market | 1,000 | $390K | 11/4/2022 | View on chart |
| CECO | ▲ Buy | Open Market | 20,000 | $179K | 8/9/2022 | View on chart |
| ROP | ▲ Buy | Grant | 1,034 | $0 | 6/16/2022 | View on chart |
| CECO | ▲ Buy | Grant | 11,941 | $0 | 6/8/2022 | View on chart |
| CRL | ▲ Buy | Grant | 575 | $0 | 5/11/2022 | View on chart |
| CRL | ▲ Buy | Grant | 360 | $0 | 5/11/2022 | View on chart |
| CECO | ▲ Buy | Open Market | 16,913 | $97K | 3/22/2022 | View on chart |
| CECO | ▲ Buy | Open Market | 13,087 | $77K | 3/21/2022 | View on chart |
| CRL | ▼ Sell | Open Market | 3,250 | $936K | 2/22/2022 | View on chart |
| CRL | ▼ Sell | Open Market | 2,800 | $833K | 2/18/2022 | View on chart |
| CRL | ▼ Sell | Open Market | 425 | $125K | 2/18/2022 | View on chart |
| CRL | ▼ Sell | Open Market | 725 | $214K | 2/18/2022 | View on chart |
| CECO | ▲ Buy | Open Market | 9,574 | $58K | 12/21/2021 | View on chart |
| CECO | ▲ Buy | Open Market | 5,426 | $32K | 12/20/2021 | View on chart |
| ROP | ▼ Sell | Open Market | 1,000 | $474K | 12/15/2021 | View on chart |
| ROP | ▼ Sell | Open Market | 500 | $238K | 12/14/2021 | View on chart |
| ROP | ▼ Sell | Open Market | 1,250 | $594K | 12/14/2021 | View on chart |
| ROP | ▼ Sell | Open Market | 2,000 | $951K | 12/13/2021 | View on chart |
| CECO | ▲ Buy | Open Market | 16,310 | $99K | 12/10/2021 | View on chart |
| CECO | ▲ Buy | Open Market | 8,160 | $50K | 12/10/2021 | View on chart |
| CECO | ▲ Buy | Open Market | 3,690 | $23K | 12/9/2021 | View on chart |
| CECO | ▲ Buy | Open Market | 1,840 | $11K | 12/9/2021 | View on chart |
| CECO | ▲ Buy | Grant | 5,881 | $0 | 11/4/2021 | View on chart |
| ROP | ▼ Sell | Gift | 10,715 | $0 | 10/18/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Roper Technologies to Report Earnings Next Week
Roper Technologies is preparing to release its next earnings report, with analysts expecting revenue growth. The company also recently launched a new PowerPlan Enterprise Adapter for Oracle Fusion Cloud ERP, expanding its software integration capabilities. These developments provide key context as investors await the upcoming financial results.
Roper Technologies to Report Earnings Next Week. Roper Technologies is preparing to release its next earnings report, with analysts expecting revenue growth. The company also recently launched a new PowerPlan Enterprise Adapter for Oracle Fusion Cloud ERP, expanding its software integration capabilities. These developments provide key context as investors await the upcoming financial results.